Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar;56(3):385-9.
doi: 10.1136/gut.2006.099150. Epub 2006 Sep 27.

Rate and predictors of treatment prescription for hepatitis C

Affiliations

Rate and predictors of treatment prescription for hepatitis C

Adeel A Butt et al. Gut. 2007 Mar.

Abstract

Background: The true treatment rate for hepatitis C virus (HCV) in veterans is unknown.

Aim: To determine the treatment prescription rates and predictors of treatment prescription for HCV in a large national population.

Methods: The Department of Veterans Affairs National Patient Care Database (NPCD) was used to identify all HCV-infected people between the fiscal years 1999 and 2003 using the International classification of diseases, 9th revision codes. Demographic information, medical and psychiatric comorbidities, and drug and alcohol use diagnoses were retrieved. Pharmacy data were retrieved from the Department of Veterans Affairs Pharmacy Benefits Management (PBM) database. Logistic regression analysis was used to determine the predictors of treatment for HCV in HCV.

Results: 113 927 veterans in the Department of Veterans Affairs care with a diagnosis of HCV were identified. The treatment prescription rate for HCV was 11.8%. Patients not prescribed treatment were older, more likely to be from minority races, have more alcohol and drug misuse, and have medical and psychiatric comorbid conditions. In a multivariate logistic regression model, the following factors were predictive of non-treatment for HCV: increasing age (odds ratio (OR) 0.77 for each 5-year increase in age; 95% confidence interval (CI) 0.76 to 0.78); black race (OR 0.64; 95% CI 0.6 to 0.68); Hispanic race (OR 0.88; 95% CI 0.8 to 0.96); alcohol abuse and dependence (OR 0.62; 95% CI 0.59 to 0.65); drug abuse and dependence (OR 0.78; 95% CI 0.74 to 0.82); anaemia (OR 0.18; 95% CI 0.16 to 0.21); hepatitis B infection (OR 0.72; 95% CI 0.62 to 0.83); coronary artery disease (OR 0.9; 95% CI 0.85 to 0.97); stroke (OR 0.75; 95% CI 0.67 to 0.85); bipolar disorder (OR 0.64; 95% CI 0.58 to 0.70); major depression (OR 0.72; 95% CI 0.67 to 0.77); mild depression (OR 0.56; 95% CI 0.53 to 0.59); and schizophrenia (OR 0.71; 95% CI 0.65 to 0.77). The following factors were associated with a higher likelihood of treatment prescription for HCV: liver cirrhosis (OR 1.6; 95% CI 1.5 to 1.7); and diabetes (OR 1.07; 95% CI 1.02 to 1.12).

Conclusions: A small number of HCV-infected veterans were prescribed treatment for HCV. Non-treatment is associated with increasing age, non-white race, drug and alcohol abuse, and dependence and comorbid illnesses. Reasons for non-treatment need further study.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

Cited by

References

    1. Thomas D L, Astemborski J, Rai R M.et al The natural history of hepatitis C infection. Host, viral and environmental factors. JAMA 2000284450–456. - PubMed
    1. Alter M J, Kruszon‐Moran D, Nainan O V.et al The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999341556–562. - PubMed
    1. Tong M J, El Farra N S, Reikes A R.et al Clinical outcomes after transfusion‐associated hepatitis C. N Engl J Med 19953321463–1466. - PubMed
    1. Liang T J, Rehermann B, Seeff L B.et al Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Int Med 2000132296–305. - PubMed
    1. Manns M P, McHutchinson J G, Gordon S C.et al Peginterferon alfa‐2b plus ribavirin compared with interferon alfa‐2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001358958–965. - PubMed

Publication types

MeSH terms

Substances